NCT03434769: AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma |
|
|
| Active, not recruiting | 1 | 31 | US | Cyclophosphamide, Cytoxan, Endoxan, Neosar, Procytox, Revimmune, Cycloblastin, Fludarabine, Fludara, CAR-T Cells | Benjamin Tomlinson | Non-Hodgkin Lymphoma | 03/23 | 02/36 | | |
NCT04732845: Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies |
|
|
| Recruiting | 1 | 36 | US | Fully human anti CD19 CAR-T Cell Dose, Fludarabine, Fludara, Cyclophosphamide, Cytoxan, Endoxan, Neosar, Procytox, Revimmune, Cycloblastin | Benjamin Tomlinson | Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia | 06/24 | 12/24 | | |
